News

Cases of the inflammatory heart event occurred 1626 times after an mRNA vaccine dose in US patients from December 2020 to August 2021.

The renowned expert joins to discuss the clinical characteristics, societal burdens, and promising therapy research surrounding the hematologic disease.

Dr. Brown discusses the most common conditions of patients treated for ocular trauma and highlights the range of performed procedures in the ED.

Investigators believe the data highlighted the importance of improving and maintaining adequate sleep duration as a public health target for obesity prevention.

The investigators found 56.7% of nursing home patients and 68.1% had multi-drug resistant organism-positive results at enrollment.

New data from the ECZTRA 6 trial noted improvements in itch, sleep interference, anxiety and more.

The NDA has been assigned standard review with a PDUFA target action date in late November 2022.

The monoclonal antibody is designed to reduce the need for red blood cell transfusions to hemolysis among adults with the rare disease.

Experts explain that their analysis clearly lays out how lack of effective regulation and an unchecked profit motive created the opioid epidemic.

Previous contrasting studies found that omalizumab was less effective in reducing exacerbations in obese patients.

No difference was observed between atrial shunt placement and sham in the endpoint of CVD death, non-fatal ischemic stroke at 12 months, and rate of total heart failure events at 24 months.

In commemoration of Wear Red Day, here's a breakdown of how US regions differ in cardiovascular disease burden among women.

A systematic review and meta-analysis from a trio of authors argues against the use of government-mandated non-pharmaceutical interventions to curb a pandemic.

Knowing the symptoms and risk factors of CVD unique to women can aid in awareness and prevention efforts.

Dr. Poornima explores improving engagement in women’s cardiovascular care from both a provider and a patient level.

Cardiovascular disease is the leading cause of death for women.

Women with high social isolation and high loneliness scores had a 13.0% - 27.0% higher risk of incident CVD compared to women with low scores.

Dr. Radhakrishnan discusses both the effects of gender bias and why women don't get screened for heart disease.

On Wear Red Day, Dr. Ivanova advocates for increased awareness and diversity in women's cardiovascular care.

A total of 45 studies were selected for the systematic review, with non-White patients being underrepresented across them all.

New findings observing links between visual acuity, disease progression and risk loci could inform new clinical studies of the leading cause of irreversible vision loss.

Future studies should focus on subgroups of patients with Crohn’s disease treated with ustekinumab.

Dr. Greenberg urges the ACIP to update their vaccine guidelines for patients 65 years and older to recommend high-dose flu vaccines.

Monthly IV pegcetacoplan was associated with 39% reduced risk of progression from incomplete to complete RPE and outer retinal atrophy.

February 3 is National Women's Physician Day.

Both single-donor and multiple-donor fecal microbiota transplantation had clinical cure rates over 80%.